Eating Disorders Trial, Recruiting (NCT05763849)

Eating Disorders Trial, Recruiting NCT05763849 Sponsor: Icahn School of Medicine at Mount Sinai Condition: Eating Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT05763849 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Eating Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 12 and 18 years old
You are able to speak English
Your pediatrician or similar doctor has given permission for you to receive care outside of a hospital setting
You have a clinically significant restriction in how much food you eat, based on a specific assessment tool (EDA-5), or there is clear evidence of ongoing food avoidance reported by you or your guardians
You have difficulty maintaining a healthy body weight for your age and growth stage, based on your BMI percentile and growth history

Who may not be able to join:

You have been diagnosed with a psychotic disorder or bipolar disorder alongside your current condition
You are currently having active thoughts of suicide
You are currently dependent on substances such as drugs or alcohol
You have started a new psychiatric medication or had your medication dose changed less than 2 weeks before the start of the trial
You have a significant ongoing medical condition, such as diabetes or Crohn's disease (confirm with trial site for other conditions that may apply)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Thomas Hildebrandt, Psy.D., Icahn School of Medicine at Mount Sinai

Phone: (212) 659-8673

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05763849

Sponsor: Icahn School of Medicine at Mount Sinai

Phase: Not Applicable

Status: Recruiting

Condition: Eating Disorders

Trial contact: (212) 659-8673

More information: https://clinicaltrials.gov/study/NCT05763849

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 12 and 18 years old
You are able to speak English
Your pediatrician or similar doctor has given permission for you to receive care outside of a hospital setting
You have a clinically significant restriction in how much food you eat, based on a specific assessment tool (EDA-5), or there is clear evidence of ongoing food avoidance reported by you or your guardians
You have difficulty maintaining a healthy body weight for your age and growth stage, based on your BMI percentile and growth history

Who may not be able to join:

You have been diagnosed with a psychotic disorder or bipolar disorder alongside your current condition
You are currently having active thoughts of suicide
You are currently dependent on substances such as drugs or alcohol
You have started a new psychiatric medication or had your medication dose changed less than 2 weeks before the start of the trial
You have a significant ongoing medical condition, such as diabetes or Crohn's disease (confirm with trial site for other conditions that may apply)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Icahn School of Medicine at Mount Sinai

Registry

ClinicalTrials.gov

Start date

14 March 2023

Est. completion

1 January 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Expected Body Weight Percentage; Change in Expected Body Weight Percentage; Change in Impairment; Change in Impairment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov